Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30.
Published August 10, 2022 · Recall initiated: July 21, 2022
Summary
FDA records drug Class II recall D-1303-2022, published August 10, 2022 and initiated July 21, 2022. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 5677 bottles; Lot: Lot 1411596A, Exp 09/22. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: below specification limits for dissolution.
What to do
Voluntary: Firm initiated
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Teva Pharmaceuticals USA Inc
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot 1411596A, Exp 09/22
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASunitinib Malate Capsules, 12.5 mg, 28-count bottles, Rx only, Manufactured By: Teva Pharmaceuticals USA,July 19, 2023
- FDAFentanyl Buccal Tablets CII, 600mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only,May 31, 2023
- FDAFentanyl Buccal Tablets CII, 400mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only,May 31, 2023
- FDAFentanyl Buccal Tablets CII, 200mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only,May 31, 2023
- FDAMatzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, ManufacturedAugust 10, 2022
- FDATacrolimus Ointment, 0.1%, For Dermatological Use Only, Not for Ophthalmic Use, Rx Only, a) 30 g tube, NDCAugust 10, 2022
Questions about this recall
Was Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30. recalled?
Yes. FDA published recall D-1303-2022 on August 10, 2022. Reported hazard: Failed Dissolution Specifications: below specification limits for dissolution.
What should I do if I have this product?
Voluntary: Firm initiated